Table 4.
SAEs Occurring in ≥5.0% of Patients
| N = 89 | ||
|---|---|---|
| Parameter (preferred terms) | n (%) | Number of events |
| Any SAE | 69 (77.5) | 254 |
| Pyrexia | 25 (28.1) | 36 |
| Device‐related infectiona | 24 (27.0) | 36 |
| Influenza | 9 (10.1) | 9 |
| Device breakagea | 8 (9.0) | 9 |
| Dehydration | 7 (7.9) | 12 |
| Upper respiratory tract infection | 6 (6.7) | 6 |
SAE, serious adverse event.
aAll device‐related events were related to central venous catheters used to administer parenteral support, not to the teduglutide injection device.